In Vitro Mineralisation of Tissue-Engineered Cartilage Reduces Endothelial Cell Migration, Proliferation and Tube Formation.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
20 04 2023
Historique:
received: 15 02 2023
revised: 14 04 2023
accepted: 18 04 2023
medline: 17 5 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: epublish

Résumé

Tissue engineering bone via endochondral ossification requires the generation of a cartilage template which undergoes vascularisation and remodelling. While this is a promising route for bone repair, achieving effective cartilage vascularisation remains a challenge. Here, we investigated how mineralisation of tissue-engineered cartilage affects its pro-angiogenic potential. To generate in vitro mineralised cartilage, human mesenchymal stromal cell (hMSC)-derived chondrogenic pellets were treated with β-glycerophosphate (BGP). After optimising this approach, we characterised the changes in matrix components and pro-angiogenic factors by gene expression analysis, histology and ELISA. Human umbilical vein endothelial cells (HUVECs) were exposed to pellet-derived conditioned media, and migration, proliferation and tube formation were assessed. We established a reliable strategy to induce in vitro cartilage mineralisation, whereby hMSC pellets are chondrogenically primed with TGF-β for 2 weeks and BGP is added from week 2 of culture. Cartilage mineralisation determines loss of glycosaminoglycans, reduced expression but not protein abundance of collagen II and X, and decreased VEGFA production. Finally, the conditioned medium from mineralised pellets showed a reduced ability to stimulate endothelial cell migration, proliferation and tube formation. The pro-angiogenic potential of transient cartilage is thus stage-dependent, and this aspect must be carefully considered in the design of bone tissue engineering strategies.

Identifiants

pubmed: 37190110
pii: cells12081202
doi: 10.3390/cells12081202
pmc: PMC10136546
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Trends Cell Biol. 2004 Feb;14(2):86-93
pubmed: 15102440
J Tissue Eng Regen Med. 2012 Jan;6(1):68-76
pubmed: 21305699
Arthritis Rheum. 2006 Oct;54(10):3254-66
pubmed: 17009260
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3311-6
pubmed: 20133604
J Cell Biochem. 1994 Jul;55(3):350-7
pubmed: 7962167
Calcif Tissue Int. 2005 May;76(5):379-84
pubmed: 15834504
Cartilage. 2021 Dec;13(2_suppl):559S-570S
pubmed: 34590881
Front Bioeng Biotechnol. 2020 Apr 17;8:327
pubmed: 32363188
J Bone Miner Metab. 2002;20(3):142-7
pubmed: 11984696
J Bone Miner Res. 2003 Aug;18(8):1430-42
pubmed: 12929932
J Bone Miner Res. 1999 Feb;14(2):273-80
pubmed: 9933482
Stem Cells. 2013 Nov;31(11):2420-31
pubmed: 23897668
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7251-6
pubmed: 20406908
Arthritis Res Ther. 2010;12(5):216
pubmed: 20959023
Eur Cell Mater. 2017 Sep 22;34:142-161
pubmed: 28937176
Front Cell Dev Biol. 2021 May 13;9:674084
pubmed: 34079804
J Mol Med (Berl). 1995 Jul;73(7):333-46
pubmed: 8520966
Histochem Cell Biol. 2003 Sep;120(3):235-41
pubmed: 12904969
Bone. 2018 Feb;107:10-17
pubmed: 29107125
Proc Natl Acad Sci U S A. 2008 May 13;105(19):6840-5
pubmed: 18467492
Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9637-42
pubmed: 15976027
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1381-7
pubmed: 18385273
Biomaterials. 2009 May;30(14):2816-25
pubmed: 19232714
Tissue Eng. 2004 Jul-Aug;10(7-8):978-86
pubmed: 15363155
Microsc Res Tech. 1998 Oct 15;43(2):191-204
pubmed: 9823004
J Bone Miner Res. 2006 May;21(5):735-44
pubmed: 16734388
Anat Rec. 1990 Jun;227(2):223-31
pubmed: 2350011
In Vitro Cell Dev Biol Anim. 1995 Apr;31(4):274-82
pubmed: 7795846
Am J Pathol. 2003 Jan;162(1):171-81
pubmed: 12507900
Biochem J. 2002 Jun 1;364(Pt 2):329-41
pubmed: 12023876
Ann N Y Acad Sci. 2003 May;995:109-16
pubmed: 12814943
Tissue Eng Part A. 2017 Dec;23(23-24):1466-1478
pubmed: 28756737
J Clin Med. 2019 Oct 03;8(10):
pubmed: 31623330
Tissue Eng. 2006 Jul;12(7):1721-31
pubmed: 16889503
Tissue Eng Part C Methods. 2009 Jun;15(2):285-95
pubmed: 19505182
Calcif Tissue Int. 2003 Aug;73(2):161-72
pubmed: 14565598
J Tissue Eng Regen Med. 2015 Aug;9(8):889-902
pubmed: 24916192
Stem Cells. 2016 Dec;34(12):2956-2966
pubmed: 27538760
Tissue Eng Part A. 2016 Oct;22(19-20):1176-1190
pubmed: 27604384
Stem Cells Transl Med. 2015 Aug;4(8):894-8
pubmed: 26025982
J Tissue Eng Regen Med. 2011 Oct;5(9):747-58
pubmed: 21953872
Bioengineering (Basel). 2018 Aug 12;5(3):
pubmed: 30103544
Biochem Biophys Res Commun. 2002 Apr 5;292(3):727-33
pubmed: 11922626
Biomaterials. 2006 May;27(14):2798-805
pubmed: 16430957
Crit Rev Eukaryot Gene Expr. 2009;19(3):219-33
pubmed: 19883366
BMC Musculoskelet Disord. 2011 Jan 31;12:31
pubmed: 21281488
Bone. 2004 Aug;35(2):535-42
pubmed: 15268906
Biomaterials. 2004 Mar;25(6):971-7
pubmed: 14615161
Angiogenesis. 2020 May;23(2):179-192
pubmed: 31754927
Front Bioeng Biotechnol. 2020 Mar 31;8:230
pubmed: 32296687
J Oral Biosci. 2022 Mar;64(1):18-25
pubmed: 34915120
Stem Cells Dev. 2016 Jan 15;25(2):123-38
pubmed: 26528828
J Theor Biol. 2008 Mar 7;251(1):137-58
pubmed: 18155732
Exp Cell Res. 1998 Feb 1;238(2):491-7
pubmed: 9473358
Tissue Eng Part A. 2009 Nov;15(11):3669-77
pubmed: 19499998
Eur Cell Mater. 2019 Sep 18;38:106-122
pubmed: 31532540
Arthritis Rheum. 2008 Apr;58(4):1076-85
pubmed: 18383360
Kidney Int. 2013 Feb;83(2):213-22
pubmed: 22913982

Auteurs

Encheng Ji (E)

Department of Oral and Maxillofacial Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Lieke Leijsten (L)

Department of Oral and Maxillofacial Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Janneke Witte-Bouma (J)

Department of Oral and Maxillofacial Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Adelin Rouchon (A)

Department of Biomedicine, Basel University Hospital, University of Basel, 4031 Basel, Switzerland.

Nunzia Di Maggio (N)

Department of Biomedicine, Basel University Hospital, University of Basel, 4031 Basel, Switzerland.

Andrea Banfi (A)

Department of Biomedicine, Basel University Hospital, University of Basel, 4031 Basel, Switzerland.

Gerjo J V M van Osch (GJVM)

Department of Orthopaedics and Sports Medicine, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Department of Otorhinolaryngology, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Department of Biomechanical Engineering, University of Technology Delft, 2628 CD Delft, The Netherlands.

Eric Farrell (E)

Department of Oral and Maxillofacial Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Andrea Lolli (A)

Department of Oral and Maxillofacial Surgery, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH